Why Marijuana Legalization Could Give Medicinal Sales a Boost Too

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has seen medicinal marijuana sales soar in recent years, but there are still opportunities for even more growth ahead.

Marijuana legislation was passed earlier this year and recreational pot sales are expected to commence in mid-October, and while medical marijuana has been legalized for some time now, it too could benefit from the new law.

It’s not as if companies are struggling to sell medical marijuana, but legalization will make it easier for patients and those looking for the benefits of cannabidiol to get easier access to cannabis.

Canopy Growth Corp. (TSX: WEED)(NYSE:CGC) and others in the industry have had to rely on medicinal sales so far, and while there has been grown in that segment, there’s clearly much more that could be achieved. In its most recent fiscal year, Canopy Growth recorded $78 million in sales, which is nearly double the $40 million it recorded in the prior year and triple the revenue it booked in 2016.

Sales have been growing at a strong pace — and that’s with medical marijuana still not being covered by most healthcare plans in the country.

What’s holding medical marijuana back?

In a recent interview with the CBC, Dr. Jeff Blackmer of the Canadian Medical Association said that many doctors are still hesitant to prescribe medical marijuana, simply because the benefits remain unclear. A big reason for that is there have been limited studies and testing done on marijuana, which has made it harder to validate its effectiveness in treating patients.

While there are no big obstacles holding back research in Canada, in the U.S., where lots of money is spent on researching various drugs, because marijuana is a Schedule I drug, some big hurdles that prevent cannabis research. Until we see marijuana legalized federally south of the border, the studies we see on cannabis are going to remain limited.

This brings us back to where we are today, and why legalization will open the doors not only for recreational users, but medicinal ones as well. Without relying on a doctor’s prescription, patients can freely seek out cannabis in order to help with their ailments. And although it hasn’t generally been hard to get a prescription for marijuana, legalization will make it even easier to do so, which should enable even more patients to get access to cannabis.

Still many opportunities ahead

Medical marijuana will get a boost from legalization, but without doctors endorsing it or healthcare plans covering it, there will still be patients who remain hesitant to try it without their physician’s recommendation and with the cost not being covered.

Once those hurdles are cleared, we could see even more demand for medical marijuana, and it won’t be until then that its full potential will be realized.

Unfortunately, it could still take many years before we see that happen, and it will be dependent on what studies happen in the future. As countries around the world take steps in legalizing marijuana, we’ll see more data on cannabis come in, but the turning point will be if and when the drug is legalized in the U.S.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Investing

An investor uses a tablet
Bank Stocks

Brokerage Account Basics: What Canadian Beginners Should Look For

New to investing in Canada? Learn to compare brokerage fees, pick a TFSA, RRSP or FHSA, and see why Royal…

Read more »

Metals
Energy Stocks

What Happens Next After Ottawa’s Deadline for Stelco

Stelco's owner has defended its layoffs, but Ottawa's deadline doesn't automatically settle the jobs dispute or the investment case.

Read more »

Safety helmets and gloves hang from a rack on a mining site.
Stocks for Beginners

Canada Lost 68,000 Jobs in September: The October 28 Rate Call Just Got Harder

September's job losses complicate the rate decision, while Scotiabank shows why borrowers' relief and bank earnings aren't the same thing.

Read more »

Canadian energy stocks are rising with oil prices
Energy Stocks

Diesel Is Running Short Worldwide: The Canadian Refiner Cashing In

Suncor's refining margins show how tight fuel supplies can support cash, while a modest dividend yield keeps expectations realistic.

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

How I’d Structure My $14,000 TFSA for Constant Income

If you have $14,000 saved in your TFSA, here is one easy investment strategy to earn $50 of tax-free monthly…

Read more »

telehealth stocks
Tech Stocks

1 Canadian Stock Down 42% to Buy and Hold Forever

This health tech stock is trading at a discount as it continues to grow and expand a business very much…

Read more »

woman looks at iPhone
Dividend Stocks

I’m Not Selling Telus After the 55% Dividend Cut: Here’s Why

Contrary to what the market seems to be saying, Telus Corporation (TSX: T) still has a lot going for it.…

Read more »

monthly calendar with clock
Dividend Stocks

A No-Nonsense 3.7% Dividend Stock That Can Pay Retirees Monthly

This no-nonsense dividend stock has returned more than $3.4 billion to shareholders through dividends since 2013.

Read more »